• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number VBH110502A
Medical Device Problem Code Premature Separation (4045)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 11/19/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface, and is essentially non-eluting.
 
Event or Problem Description
The following information was reported to gore: on (b)(6) 2020, a patient was undergoing a procedure of unknown type with a gore® viabahn® endoprosthesis.After inserting the device, a separation between the stent and the catheter was noticed.Additionally, the stent was in a position where it would not deploy properly the device and delivery system were removed, and another device was utilized successfully.
 
Additional Manufacturer Narrative
The information initially reported stated the stent had separated from the delivery catheter.After the device was returned an engineering evaluation was performed.It was identified that the stent moved on the distal shaft but did not separate from the delivery catheter.Therefore this report will be retracted.The gore® viabahn® endoprosthesis instructions for use states, ¿do not withdraw the gore® viabahn® endoprosthesis back into the introducer sheath after the endoprosthesis is fully introduced¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
heidi inskeep
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key10880284
Report Number2017233-2020-01476
Device Sequence Number11844570
Product Code NIP
UDI-Device Identifier00733132623259
UDI-Public00733132623259
Combination Product (Y/N)Y
Initial Reporter StateHI
Initial Reporter CountryUS
PMA/510(K) Number
P40037
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/30/2022
Device Model NumberVBH110502A
Device Catalogue NumberVBH110502A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/20/2020
Supplement Date Received by Manufacturer11/20/2020
Initial Report FDA Received Date11/20/2020
Supplement Report FDA Received Date06/14/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured05/01/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-